skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Monoclonal Antibodies remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Charles, Pierre ; Terrier, Benjamin ; Perrodeau, Élodie ; Cohen, Pascal ; Faguer, Stanislas ; Huart, Antoine ; Hamidou, Mohamed ; Agard, Christian ; Bonnotte, Bernard ; Samson, Maxime ; Karras, Alexandre ; Jourde-Chiche, Noémie ; Lifermann, François ; Gobert, Pierre ; Hanrotel-Saliou, Catherine ; Godmer, Pascal ; Martin-Silva, Nicolas ; Pugnet, Grégory ; Matignon, Marie ; Aumaitre, Olivier ; Viallard, Jean-François ; Maurier, François ; Meaux-Ruault, Nadine ; Rivière, Sophie ; Sibilia, Jean ; Puéchal, Xavier ; Ravaud, Philippe ; Mouthon, Luc ; Guillevin, Loïc

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1143-1149 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
2
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matasar, Matthew J ; Capra, Marcelo ; Özcan, Muhit ; Lv, Fangfang ; Li, Wei ; Yañez, Eduardo ; Sapunarova, Katya ; Lin, Tongyu ; Jin, Jie ; Jurczak, Wojciech ; Hamed, Aryan ; Wang, Ming-Chung ; Baker, Ross ; Bondarenko, Igor ; Zhang, Qingyuan ; Feng, Jifeng ; Geissler, Klaus ; Lazaroiu, Mihaela ; Saydam, Guray ; Szomor, Árpád ; Bouabdallah, Krimo ; Galiulin, Rinat ; Uchida, Toshiki ; Soler, Lidia Mongay ; Cao, Anjun ; Hiemeyer, Florian ; Mehra, Aruna ; Childs, Barrett H ; Shi, Yuankai ; Zinzani, Pier Luigi

The lancet oncology, 2021-05, Vol.22 (5), p.678-689 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

Fluge, Øystein ; Risa, Kristin ; Lunde, Sigrid ; Alme, Kine ; Rekeland, Ingrid Gurvin ; Sapkota, Dipak ; Kristoffersen, Einar Kleboe ; Sørland, Kari ; Bruland, Ove ; Dahl, Olav ; Mella, Olav van der Feltz-Cornelis, Christina

PloS one, 2015-07, Vol.10 (7), p.e0129898 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
4
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients

Pfreundschuh, Michael ; Murawski, Niels ; Zeynalova, Samira ; Ziepert, Marita ; Loeffler, M. ; Hänel, Matthias ; Dierlamm, Judith ; Keller, Ulrich ; Dreyling, Martin ; Truemper, Lorenz ; Frickhofen, Norbert ; Hünerlitürkoglu, Ali‐Nuri ; Schmitz, Norbert ; Pöschel, Viola ; Rixecker, Tanja ; Berdel, Christian ; Rübe, Christian ; Held, Gerhard ; Zwick, Carsten

British journal of haematology, 2017-11, Vol.179 (3), p.410-420 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
A tale of two antibodies: obinutuzumab versus rituximab
A tale of two antibodies: obinutuzumab versus rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A tale of two antibodies: obinutuzumab versus rituximab

Freeman, Ciara L. ; Sehn, Laurie H.

British journal of haematology, 2018-07, Vol.182 (1), p.29-45 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, Hervé ; Morschhauser, Franck ; Sehn, Laurie H ; Friedberg, Jonathan W ; Trněný, Marek ; Sharman, Jeff P ; Herbaux, Charles ; Burke, John M ; Matasar, Matthew ; Rai, Shinya ; Izutsu, Koji ; Mehta-Shah, Neha ; Oberic, Lucie ; Chauchet, Adrien ; Jurczak, Wojciech ; Song, Yuqin ; Greil, Richard ; Mykhalska, Larysa ; Bergua-Burgués, Juan M ; Cheung, Matthew C ; Pinto, Antonio ; Shin, Ho-Jin ; Hapgood, Greg ; Munhoz, Eduardo ; Abrisqueta, Pau ; Gau, Jyh-Pyng ; Hirata, Jamie ; Jiang, Yanwen ; Yan, Mark ; Lee, Calvin ; Flowers, Christopher R ; Salles, Gilles

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Advani, Ranjana ; Flinn, Ian ; Popplewell, Leslie ; Forero, Andres ; Bartlett, Nancy L ; Ghosh, Nilanjan ; Kline, Justin ; Roschewski, Mark ; LaCasce, Ann ; Collins, Graham P ; Tran, Thu ; Lynn, Judith ; Chen, James Y ; Volkmer, Jens-Peter ; Agoram, Balaji ; Huang, Jie ; Majeti, Ravindra ; Weissman, Irving L ; Takimoto, Chris H ; Chao, Mark P ; Smith, Sonali M

The New England journal of medicine, 2018-11, Vol.379 (18), p.1711-1721 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Shanafelt, Tait D ; Wang, Xin V ; Kay, Neil E ; Hanson, Curtis A ; O’Brien, Susan ; Barrientos, Jacqueline ; Jelinek, Diane F ; Braggio, Esteban ; Leis, Jose F ; Zhang, Cong C ; Coutre, Steven E ; Barr, Paul M ; Cashen, Amanda F ; Mato, Anthony R ; Singh, Avina K ; Mullane, Michael P ; Little, Richard F ; Erba, Harry ; Stone, Richard M ; Litzow, Mark ; Tallman, Martin

The New England journal of medicine, 2019-08, Vol.381 (5), p.432-443 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
9
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis

Pepper, Ruth J ; McAdoo, Stephen P ; Moran, Sarah M ; Kelly, Dearbhla ; Scott, Jennifer ; Hamour, Sally ; Burns, Aine ; Griffith, Megan ; Galliford, Jack ; Levy, Jeremy B ; Cairns, Thomas D ; Gopaluni, Seerapani ; Jones, Rachel B ; Jayne, David ; Little, Mark A ; Pusey, Charles D ; Salama, Alan D

Rheumatology (Oxford, England), 2019-02, Vol.58 (2), p.260-268 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
10
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Woyach, Jennifer A ; Ruppert, Amy S ; Heerema, Nyla A ; Zhao, Weiqiang ; Booth, Allison M ; Ding, Wei ; Bartlett, Nancy L ; Brander, Danielle M ; Barr, Paul M ; Rogers, Kerry A ; Parikh, Sameer A ; Coutre, Steven ; Hurria, Arti ; Brown, Jennifer R ; Lozanski, Gerard ; Blachly, James S ; Ozer, Hatice G ; Major-Elechi, Brittny ; Fruth, Briant ; Nattam, Sreenivasa ; Larson, Richard A ; Erba, Harry ; Litzow, Mark ; Owen, Carolyn ; Kuzma, Charles ; Abramson, Jeremy S ; Little, Richard F ; Smith, Scott E ; Stone, Richard M ; Mandrekar, Sumithra J ; Byrd, John C

The New England journal of medicine, 2018-12, Vol.379 (26), p.2517-2528 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (4.843)
  2. Revistas revisadas por pares (4.801)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (4.853)
  2. Anais de Congresso  (23)
  3. Book Chapters  (19)
  4. Newsletter Articles  (14)
  5. Verbetes  (4)
  6. Reports  (3)
  7. Dissertações  (1)
  8. Livros  (1)
  9. Mais opções open sub menu

Assunto 

  1. Rituximab  (4.593)
  2. Science & Technology  (3.788)
  3. Life Sciences & Biomedicine  (3.575)
  4. Immunotherapy  (2.778)
  5. Humans  (2.465)
  6. Patients  (2.123)
  7. Targeted Cancer Therapy  (1.875)
  8. Lymphoma  (1.553)
  9. Female  (1.238)
  10. Male  (1.194)
  11. Lymphocytes B  (1.059)
  12. Oncology  (949)
  13. Middle Aged  (938)
  14. Hematology  (904)
  15. Rituximab - Therapeutic Use  (862)
  16. Chemotherapy  (844)
  17. Adult  (831)
  18. Aged  (736)
  19. Remission  (701)
  20. Mais opções open sub menu

Idioma 

  1. Inglês  (4.894)
  2. Japonês  (454)
  3. Italiano  (24)
  4. Alemão  (10)
  5. Francês  (9)
  6. Norueguês  (8)
  7. Português  (8)
  8. Espanhol  (5)
  9. Polonês  (4)
  10. Russo  (4)
  11. Turco  (1)
  12. Coreano  (1)
  13. Chinês  (1)
  14. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.